The Current Biomarker Landscape in Immuno-Oncology
Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.
Imaging Biomarkers for Autoimmune Diseases
Medpace Imaging Core Lab has experience and expertise in autoimmune imaging using conventional and molecular imaging methods.
Exciting CNS Breakthroughs: Where the Promise Lies
In a recent PharmaVoice article "Brain Wave: Breakthroughs Bring New Hope to CNS", Dr. Rick Scheyer, Vice-President, Medical Affairs at Medpace, provides comment on the state of…
Medpace to Present New Biomarker Assay Validation Methods at AAPS PharmSci 360
This year at AAPS PharmSci 360, scientists from Medpace’s bioanalytical laboratory will be presenting two scientific posters regarding new methods for biomarker assay validation. Stop…
New Biomarker Assay Validations from Medpace’s Central Labs
With an already robust menu of validated assays, the increase in new biomarker assay validations speaks to the seamless service we provide to our Sponsors.
Biomarkers for Celiac Disease Clinical Trials
As a full service, global CRO with an integrated central lab, Medpace has the scientific, operational and regulatory expertise to manage your celiac disease clinical…